RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
57 hedge funds and large institutions have $129M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2017 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 30 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+2
Holders Change %
+3.64%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
30
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
$13.1M |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
$9.35M |
3 |
BlackRock
New York
|
$14.5M |
4 |
![]()
JPMorgan Chase & Co
New York
|
$7.36M |
5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
$12.9M |